Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The EBITDA margin is -1537.00%.
Reported quarterly EBITDA margin; no daily interpolation.
Limited quarterly history available
EBITDA Margin needs at least three reported quarters before a meaningful chart is shown.
EBITDA MARGIN
-1537.00%
EBITDA MARGIN AVG TTM
N/A
EBITDA MARGIN AVG 3Y
N/A
EBITDA MARGIN AVG 5Y
N/A
EBITDA MARGIN AVG 10Y
N/A
EBITDA MARGIN AVG 15Y
N/A
EBITDA MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Sagimet Biosciences Inc.
Market Cap
$285.42M
EBITDA Margin
-1537.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$285.55M
EBITDA Margin
-1475.69%
TTM Avg
-1475.69%
3Y Avg
-2002.71%
5Y Avg
-1922.41%
Market Cap
$284.31M
EBITDA Margin
-13.37%
TTM Avg
-2.68%
3Y Avg
-19.85%
5Y Avg
-36.16%
Market Cap
$282.64M
EBITDA Margin
-101.16%
TTM Avg
-95.97%
3Y Avg
-88.25%
5Y Avg
-69.69%
Market Cap
$281.54M
EBITDA Margin
-25.38%
TTM Avg
-1946.60%
3Y Avg
-1509.96%
5Y Avg
-1364.90%
Market Cap
$280.37M
EBITDA Margin
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$292.59M
EBITDA Margin
-144.24%
TTM Avg
-144.24%
3Y Avg
-144.24%
5Y Avg
-144.24%
Market Cap
$293.30M
EBITDA Margin
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Sagimet Biosciences Inc. (SGMT) | $285.42M | -1537.00% | N/A | N/A | N/A |
| Abeona Therapeutics Inc. (ABEO)vs › | $285.55M | -1475.69% | -1475.69% | -2002.71% | -1922.41% |
| Aurora Cannabis Inc. (ACB)vs › | $284.31M | -13.37% | -2.68% | -19.85% | -36.16% |
| Standard BioTools Inc. (LAB)vs › | $282.64M | -101.16% | -95.97% | -88.25% | -69.69% |
| Larimar Therapeutics, Inc. (LRMR)vs › | $288.79M | N/A | N/A | N/A | N/A |
| Fulcrum Therapeutics, Inc. (FULC)vs › | $281.54M | -25.38% | -1946.60% | -1509.96% | -1364.90% |
| BridgeBio Oncology Therapeutics Inc. (BBOT)vs › | $280.37M | N/A | N/A | N/A | N/A |
| Mobia Medical, Inc. Common Stock (MOBI)vs › | $292.59M | -144.24% | -144.24% | -144.24% | -144.24% |
| Indaptus Therapeutics, Inc. (INDP)vs › | $293.30M | N/A | N/A | N/A | N/A |
| Vanda Pharmaceuticals Inc. (VNDA)vs › | $271.81M | -64.44% | -40.40% | -20.73% | -9.01% |
Gross Margin
0.0%
EBITDA Margin
-1537.0%
Operating Margin
0.0%
Net Margin
0.0%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2023-09-30 | -372.60% |
